Winimed 10mg – Stanozolol – Deus Medical

$48.00

Availability: In Stock

Active Ingredient: Stanozolol 10mg

Tablet Count: 50 Tablets

Active Half-life: 9 Hours

Classification: Anabolic Steroid

Dosage Men: 20-50 Mg/day

Acne: Yes

Water Retention: No

Hbr: Perhaps

Hepatoxity: Yes

SKU: 101AAS-DM-0-101 Categories: , , ,

Reviews

There are no reviews yet.

Be the first to review “Winimed 10mg – Stanozolol – Deus Medical”

Your email address will not be published. Required fields are marked *

Quick Comparison

SettingsWinimed 10mg – Stanozolol – Deus Medical removeAromamed 25mg – Exemestane – Deus Medical removeClenomed 40mg – Clenbuterol – Deus Medical removeLetrozole 2.5mg – Anti-estrogen, decreases fat build-up and decreases water retention removeDianamed 10mg – Methandienone – Deus Medical removeTurimed 10mg – Turinabol – Deus Medical remove
Image
EU
EU
EU
EU
EU
EU
SKU101AAS-DM-0-101101AAS-DM-0-105101AAS-DM-0-120101AAS-HB-0-139101AAS-DM-0-117101AAS-DM-0-103
Rating
Price $48.00 $66.00 $48.00 $75.00 $40.00 $60.00
Stock
Availability
Add to cart

Add to cart

Add to cart

Add to cart

Add to cart

Add to cart

Add to cart

DescriptionActive Ingredient: Stanozolol 10mg Tablet Count: 50 Tablets Active Half-life: 9 Hours Classification: Anabolic Steroid Dosage Men: 20-50 Mg/day Acne: Yes Water Retention: No Hbr: Perhaps Hepatoxity: YesActive Ingredient: Exemestane 25 Mg Tablet Count: 25 Counts Active Half-life: 9 Hours Classification: Anabolic Steroid Dosage Men: 25-50 Mg/day Dosage Women: 5-30 Mg/day Acne: Rarely Water Retention: No Hbr: No Hepatoxity: LowTablet Count: 50 Pills Dose: 80 – 120mcg per day Cycle: 6-8 weeks. Bioavailability: 89–98% (orally) Molar mass: 277.19 Elimination half-life: 36–48 hours Metabolism: Hepatic (negligible)CTIVE INGREDIENT: Letrozole 2.5mg TABLET COUNT: 30 COUNTS ACTIVE HALF-LIFE: 9 HOURS CLASSIFICATION: ANABOLIC STEROID DOSAGE: 2.5-5 MG/DAY ACNE: RARELY WATER RETENTION: NO HBR: NO HEPATOXITY: LOW AROMATIZATION: NO Ship From: Europe
Active Ingredient: Methandienone 10mg Count: 100 Tabs Active Half-life: 5-6 Hours Classification: Anabolic Steroid Acne: Yes Concentration: 10 mg/cap Presentation: 100 Capsules (Total box 1000mg) Dosage: 20-80mg per day over the course of 6-8 weeks
Active Ingredient: Chlorodelydromethytestosterone 10mg Tablet Count: 50 Counts Active Half-life: 9 Hours Classification: Anabolic Steroids Dosage Men: 10mg /day Dosage Women: 10mg/day Acne: Rarely Water Retention: No Hbr: No Hepatoxity: Low Aromatization: Yes
ContentLetrozole is a nonsteroidal inhibitor of estrogen synthesis with antineoplastic activity. As a third-generation aromatase inhibitor, Letrozole selectively and reversibly inhibits aromatase, which may result in growth inhibition of estrogen-dependent breast cancer cells. Aromatase, a cytochrome P-450 enzyme localized to the endoplasmic reticulum of the cell and found in many tissues including those of the premenopausal ovary, liver, and breast, catalyzes the aromatization of androstenedione and testosterone into estrone and estradiol, the final step in estrogen biosynthesis. Estrogens are produced by the conversion of androgens through the activity of the aromatase enzyme. Letrozole blocks production of estrogens in this way by competitive, reversible binding to the heme of its cytochrome P450 unit. The action is specific, and letrozole does not reduce production of mineralo- or corticosteroids. In contrast, the antiestrogenic action of tamoxifen, the major medical therapy prior to the arrival of aromatase inhibitors, is due to its interfering with the estrogen receptor, rather than inhibiting estrogen production. Letrozole is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women. Side effects include signs and symptoms of hypoestrogenism. There is concern that long term use may lead to osteoporosis, which is why prescriptions of Letrozole are often accompanied by prescriptions of osteoporosis-fighting medication such as Fosamax. Letrozole has shown to reduce estrogen levels by 98 percent while raising testosterone levels. The anti-estrogen action of letrozole is preferred by athletes and bodybuilders for use during a steroid cycle to reduce bloating due to excess water retention and prevent the formation of gynecomastia related breast tissue that is a side effect of some anabolic steroids. Usage above 2.5 mg/day is known to potentially temporarily kill sex drive. Above 5mg/day for extended periods may cause kidney problems. Letrozole has also been shown to delay the fusing of the growth plates in adolescents. This may boost the effectiveness of growth hormone, and thus Letrozole is used to treat adolescents and children with short stature.
Weight
DimensionsN/AN/AN/AN/AN/AN/A
Additional information